Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose

The objective of this study was to examine the effect of renal sodium–glucose cotransporter inhibition with empagliflozin on the fasting plasma glucose (FPG) concentration and β-cell function in subjects with impaired fasting glucose (IFG). Eight subjects with normal fasting glucose (NFG) and eight...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Diabetes
Autores principales: Abdul-Ghani, Muhammad, Al Jobori, Hussein, Daniele, Giuseppe, Adams, John, Cersosimo, Eugenio, Triplitt, Curtis, DeFronzo, Ralph A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Diabetes Association 2017
Materias:
Complications
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301341/
https://ncbi.nlm.nih.gov/pubmed/28611037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-0055
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares